Literature DB >> 9927199

Strict regulation of c-Raf kinase levels is required for early organogenesis of the vertebrate inner ear.

C Sanz1, Y León, J Troppmair, U R Rapp, I Varela-Nieto.   

Abstract

Regulation of organogenesis involves a dynamic balance of the mechanisms regulating cell division, differentiation and death. Here we have investigated the pattern of expression of c-Raf kinase in the inner ear during early developmental stages and the consequences of manipulating c-Raf levels by misexpression of c-raf viral vectors in organotypic cultures of otic vesicle explants. We found that otic vesicles expressed c-Raf and its level remained constant during embryonic days 2 and 3 (E2-E3). c-Raf activity was increased in response to insulin like growth factor-I (IGF-I) and the activation by IGF-I of the c-Raf kinase pathway was a requirement to turn on cell proliferation in the otic vesicle. Overexpression of c-raf in E2.5 explants increased the proliferative response to low serum and IGF-I and blocked differentiation induced by retinoic acid. The increase in c-Raf levels also prevented nerve growth factor (NGF)-dependent induction of programmed cell death. Consistent with these results, the expression of a dominant negative c-Raf mutant potentiated retinoic acid action and decreased the rate of cell proliferation. We conclude that a strict control of c-Raf levels is essential for the co-ordination of the biological processes that operate simultaneously during early inner ear development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927199     DOI: 10.1038/sj.onc.1202312

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  c-Raf regulates cell survival and retinal ganglion cell morphogenesis during neurogenesis.

Authors:  B Pimentel; C Sanz; I Varela-Nieto; U R Rapp; F De Pablo; E J de La Rosa
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

2.  Delayed inner ear maturation and neuronal loss in postnatal Igf-1-deficient mice.

Authors:  G Camarero; C Avendano; C Fernandez-Moreno; A Villar; J Contreras; F de Pablo; J G Pichel; I Varela-Nieto
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

Review 3.  Cell death in the nervous system: lessons from insulin and insulin-like growth factors.

Authors:  Isabel Varela-Nieto; Enrique J de la Rosa; Ana I Valenciano; Yolanda León
Journal:  Mol Neurobiol       Date:  2003-08       Impact factor: 5.590

4.  Human myeloblastic leukemia cells (HL-60) express a membrane receptor for estrogen that signals and modulates retinoic acid-induced cell differentiation.

Authors:  M Ariel Kauss; Gudrun Reiterer; Rodica P Bunaciu; Andrew Yen
Journal:  Exp Cell Res       Date:  2008-07-26       Impact factor: 3.905

5.  RAF kinase activity regulates neuroepithelial cell proliferation and neuronal progenitor cell differentiation during early inner ear development.

Authors:  Marta Magariños; María R Aburto; Hortensia Sánchez-Calderón; Carmen Muñoz-Agudo; Ulf R Rapp; Isabel Varela-Nieto
Journal:  PLoS One       Date:  2010-12-28       Impact factor: 3.240

6.  C-Raf deficiency leads to hearing loss and increased noise susceptibility.

Authors:  Rocío de Iriarte Rodríguez; Marta Magariños; Verena Pfeiffer; Ulf R Rapp; Isabel Varela-Nieto
Journal:  Cell Mol Life Sci       Date:  2015-05-15       Impact factor: 9.261

Review 7.  Autophagy in the Vertebrate Inner Ear.

Authors:  Marta Magariños; Sara Pulido; María R Aburto; Rocío de Iriarte Rodríguez; Isabel Varela-Nieto
Journal:  Front Cell Dev Biol       Date:  2017-05-26

8.  TGFβ2-induced senescence during early inner ear development.

Authors:  Alejandro Gibaja; María R Aburto; Sara Pulido; Manuel Collado; Juan M Hurle; Isabel Varela-Nieto; Marta Magariños
Journal:  Sci Rep       Date:  2019-04-11       Impact factor: 4.379

Review 9.  Application of insulin-like growth factor-1 in the treatment of inner ear disorders.

Authors:  Norio Yamamoto; Takayuki Nakagawa; Juichi Ito
Journal:  Front Pharmacol       Date:  2014-09-10       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.